Symbol
Lyra Therapeutics, Inc.
Full name of the company.
MEDICAL-DRUGS
Industry name
DRUGS
Major industry name
Medical
Sector name
$0.12
Current price of the stock
$4M
Trading volume of the stock
$7.9M
Market capitalization of the company
Nano Cap
Category of market capitalization
51.92%
Long-term growth mean estimate
3.00
Mean analyst rating
936.48%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
3.64
Current ratio
100.00%
Gross profit margin
-6380.51%
Operating profit margin
-6380.51%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-6085.13%
Pretax profit margin
-6088.72%
Net profit margin
-57.58%
Measures profitability relative to shareholders' equity
-57.58%
ROE excluding intangible assets
-15.08%
Measures profitability relative to total assets
-57.58%
Measures profitability relative to invested capital
0.00
Asset turnover ratio
-
Inventory turnover ratio
-
Receivables turnover ratio
-
Average number of days it takes to collect receivables
-0.08
Measures valuation relative to earnings
-0.15
P/E based on future earnings estimates
5.37
Measures valuation relative to sales
0.38
Measures valuation relative to book value
-0.04
Measures valuation relative to operating cash flow
-0.04
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
